Author

Yelena Shvenke

Observed institution: Servier (France)

OpenAlex ID: A5042008692

Phase 2 multicenter study of pegaspargase in Japanese patients with previously untreated acute lymphoblastic leukemia

2025 · Katsuyoshi Koh, Yoshiyuki Kosaka, et al. · International Journal of Hematology · 2

Safety and Pharmacokinetics of Calaspargase Pegol in Adults with Newly Diagnosed Philadelphia-Negative ALL: A Phase 2/3 Study

2021 · Wendy Stock, Jae H Park, et al. · Blood · 2

Preliminary results of an open-label, single-arm phase 2/3 trial (SPARK-ALL) of calaspargase pegol in adults with newly diagnosed Philadelphia chromosome–negative acute lymphoblastic leukemia.

2026 · Daniel J. DeAngelo, Jae Hong Park, et al. · Journal of Clinical Oncology

ALL-269 Safety and Pharmacokinetics of Calaspargase Pegol in Adults With Newly Diagnosed Philadelphia-Negative Acute Lymphoblastic Leukemia: A Phase 2/3 Study

2022 · Wendy Stock, Jae H. Park, et al. · Clinical Lymphoma Myeloma & Leukemia

Poster: ALL-269 Safety and Pharmacokinetics of Calaspargase Pegol in Adults With Newly Diagnosed Philadelphia-Negative Acute Lymphoblastic Leukemia: A Phase 2/3 Study

2022 · Wendy Stock, Jae H. Park, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 5

Citation count: 4

H-index: 2

I10-index: